Advanced Hepatocellular Carcinoma
5 competing products in clinical development for Advanced Hepatocellular Carcinoma.
Pipeline by Phase
Phase 12
Phase 23
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CS-1008 2 mg/kg + Sorafenib + CS-1008 6/2 mg/kg + CS-1008 6/6 mg/kg + CS-1008 4 mg/kg + CS-1008 6 mg/kg | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Enzalutamide + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| Lenvatinib + Nivolumab | Eisai | Phase 2 | Completed | 35 |
| H3B-6527 | Eisai | Phase 1 | Completed | 29 |
| ARQ 197 | Kyowa Kirin | Phase 1 | Completed | 29 |